STRO vs ULTA · rev $62.0M vs P/E 17, rev $11.30B
Sutro Biopharma (STRO) versus Ulta Beauty Inc (ULTA) — a side-by-side from cached financials, not a winner call.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Ulta Beauty Inc (ULTA) is a specialty retail company listed on NASDAQ.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
Latest reported ULTA revenue for 2025-02-01 was $11.30B. Net income was $1.20B. Revenue was up 0.8% from 2024-02-03 to 2025-02-01. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
STRO currently screens at market cap $470.8M. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
Not investment advice. Open the STRO and ULTA stock pages for the full models.
Not investment advice.